GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
21.74
+0.74 (3.50%)
Oct 8, 2025, 3:41 PM EDT
GSK plc Market Cap
GSK plc has a market cap or net worth of $87.37 billion as of October 8, 2025. Its market cap has increased by 5.04% in one year.
Market Cap
87.37B
Enterprise Value
105.25B
Revenue
43.34B
Ranking
n/a
PE Ratio
18.63
Stock Price
$21.74
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has decreased from 96.45B to 87.37B, a decrease of -9.42%. That is a compound annual growth rate of -0.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 87.37B | 27.02% |
| Dec 31, 2024 | 68.79B | -8.64% |
| Dec 29, 2023 | 75.29B | 7.04% |
| Dec 30, 2022 | 70.34B | -35.43% |
| Dec 31, 2021 | 108.95B | 19.45% |
| Dec 31, 2020 | 91.20B | -21.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |